Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. RXST
6. SPGI
7. RIVN
8. LMT
9. SPY
10. BFH

Go back to Cadrenal Therapeutics Highlights Research Supporting 12-LOX Inhibition in Reducing Inflammation in Obesity and Type 2 Diabetes
(NASDAQ: CVKD) Delayed: 3.25 -0.11 (3.27%)
Previous Close $3.36    52 Week High $ 
Open $3.37    52 Week Low $ 
Day High $3.37    P/E N/A 
Day Low $3.25    EPS $ 
Volume 10,009